We provide precisely what you need, when you need it, whether you’re searching for something specific or aiming to equip an entire laboratory. Whatever you are looking for, you can be sure our team will take care of you and provide a dedicated service that’s designed entirely around you and your business.From Reagents for Immunology/Cell Biology to Reagents for Molecular Biology, Laboratory Equipment and Laboratory Consumables.
The John S. Latsis Public Benefit Foundation is a non-profit organisation established in 2005 to continue the benevolent legacy of John S. Latsis.The Foundation plans, manages, and funds programmes that cover a broad range of fields, such as education, science, arts and culture, social welfare and community development, in collaboration with civil society partners and key players within these areas. An additional, diversified branch of activities is the operation of the Neraida Floating Museum, which, by offering visitors free access and organising various events, seeks to highlight the maritime and entrepreneurial history of Greece, familiarise youth with the maritime profession, and promote environmental awareness.
Oisín is developing a highly precise, patent-pending, DNA-targeted intervention to clear these cells. As a recent study has shown, clearing senescent cells both reduces negative effects of aging pathologies and also extends median lifespan and survival.
The Company of Biologists is a not-for-profit publishing organisation dedicated to supporting and inspiring the biological community. They are run by distinguished practising scientists. They exist to profit science, not shareholders. They inspire new thinking and support the community of biologists.
The Bodossaki Foundation was established in 1972 and is one of the most respected privately owned public-benefit organizations in Greece. It is the result of a long, strenuous and consistent effort of its founder, Prodromos Bodossakis – Athanasiadis to support the state, the society and his fellow people, as a legacy of the tradition he himself carried, together with many other Greek benefactors and representatives of the Greek diaspora.
Improving the lives of patients affected by age-related diseases. Senolytic Therapeutics is a pharmaceutical company that develops novel medicines that target and eliminate damaged cells. Their mission is to advance their portfolio of therapies to clinical trials and improve the lives of those affected by diseases associated with aging. They have developed a unique technological portfolio which is based on drug therapies that eliminate senescent in age-related diseases. A member of the Life Biosciences group.
EMBO is an organization of more than 1800 leading researchers that promotes excellence in the life sciences in Europe and beyond. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a research environment where scientists can achieve their best work.
FarmaSyn S.A. was founded in 1994 by a group of Greek shareholders. We took our first steps as wholesalers of medicines and parapharmaceutical products, soon expanding into the field of pharmaceutical distribution with novel as well as generic drugs, offering new therapeutic possibilities to both doctors and patients. Today, we are a well established company in the healthcare sector thanks to our unswerving commitment to providing the quality products that are our trademark. Our vision is to provide high quality pharmaceutical products to patients and ongoing support to health professionals in their daily work. We want to create conditions that guarantee the patient receives products of assured quality conferring maximum therapeutic value. This, we believe, will make our fellow men and feel better and can be summarized in four words:“The Patient comes First!”
ELPEN is the leading Greek pharmaceutical company. With more than 850 employees, the company ranks 6th among more than 400 companies in the Greek market, with an annual turnover of €150 million (IMS data). ELPEN has been active in export activities since 1990, with an international presence in more than 60 countries worldwide and a subsidiary in Berlin, Germany, since 2009.They specialize in branded generics and originator products in CVS, CNS, respiratory, oncology and antimicrobials.Elpen’s activities include product development, production, regulatory affairs, marketing, sales, and exports. R&D is performed in 1.000m2 facilities focusing on cardiology, endocrinology, cancer, respiratory diseases and OTC.
The establishment of the SBSE has made the vision of the health professional a reality. A staff member with all the necessary knowledge and skills to frame physicians and scientists in the best way and to give patient-respected care to the patient. That was the vision, this continues to be our success! SBIE’s contribution to the qualitative upgrading of health care services has been spectacular. For the first time, the required days of hospitalization were significantly reduced!
The association aims to promote research, co-operation and exchange of information among all those interested in any aspect of cellular senescence. Cellular senescence is a programmed state of stable cell cycle arrest that is accompanied by a complex phenotype. Senescent cells play a role in physiological processes such as tumour suppression, wound healing and embryonic development, whilst paradoxically they can contribute to ageing, cancer and age-related disease.